Here are my favorite stocks:
AmeriGas Partners (NYSE:APU) has a market capitalization of $3.95 billion. The company employs 8,660 people, generates revenue of $2.921 billion and has a net income of $12.67 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $307.52 million. The EBITDA margin is 10.53 percent (the operating margin is 5.38 percent and the net profit margin 0.43 percent).
Financial Analysis: The total debt represents 52.64 percent of the company’s assets and the total debt in relation to the equity amounts to 166.40 percent. Due to the financial situation, a return on equity of -1.05 percent was realized. Twelve trailing months earnings per share reached a value of $1.01. Last fiscal year, the company paid $3.10 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 42.24, the P/S ratio is 1.35 and the P/B ratio is finally 2.80. The dividend yield amounts to 7.52 percent and the beta ratio has a value of 0.36.
| Long-Term Stock History Chart Of AmeriGas Partners (APU) |
| Long-Term Dividends History of AmeriGas Partners (APU) |
| Long-Term Dividend Yield History of AmeriGas Partners (APU) |
AstraZeneca (NYSE:AZN) has a market capitalization of $55.70 billion. The company employs 57,200 people, generates revenue of $27.973 billion and has a net income of $6.327 billion. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $10.666 billion. The EBITDA margin is 38.13 percent (the operating margin is 29.13 percent and the net profit margin 22.62 percent).
Financial Analysis: The total debt represents 19.26 percent of the company’s assets and the total debt in relation to the equity amounts to 43.43 percent. Due to the financial situation, a return on equity of 26.81 percent was realized. Twelve trailing months earnings per share reached a value of $4.98. Last fiscal year, the company paid $2.80 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 8.97, the P/S ratio is 1.98 and the P/B ratio is finally 2.35. The dividend yield amounts to 6.27 percent and the beta ratio has a value of 0.63.
| Long-Term Stock History Chart Of AstraZeneca (AZN) |
| Long-Term Dividends History of AstraZeneca (AZN) |
| Long-Term Dividend Yield History of AstraZeneca (AZN) |
Reynolds American (NYSE:RAI) has a market capitalization of $24.82 billion. The company employs 5,000 people, generates revenue of $8.304 billion and has a net income of $1.272 billion. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $2.345 billion. The EBITDA margin is 28.24 percent (the operating margin is 26.66 percent and the net profit margin 15.32 percent).
Financial Analysis: The total debt represents 30.77 percent of the company’s assets and the total debt in relation to the equity amounts to 96.92 percent. Due to the financial situation, a return on equity of 22.11 percent was realized. Twelve trailing months earnings per share reached a value of $1.99. Last fiscal year, the company paid $2.33 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 22.58, the P/S ratio is 2.99 and the P/B ratio is finally 4.72. The dividend yield amounts to 5.26 percent and the beta ratio has a value of 0.58.
| Long-Term Stock History Chart Of Reynolds American (RAI) |
| Long-Term Dividends History of Reynolds American (RAI) |
| Long-Term Dividend Yield History of Reynolds American (RAI) |
![]() |
| 30 High-Yield Dividend Growth Stocks (Click to enlarge) |


No comments:
Post a Comment
Do you have any questions or notes to this article?
Please let me know your thoughts and we will discuss it.